CardioComm Solutions, Inc.

CardioComm Solutions, Inc.

July 10, 2009 18:11 ET

CardioComm Solutions, Inc. Receives Notice of Legal Action and Believes Claims Are Without Merit

VICTORIA, BRITISH COLUMBIA--(Marketwire - July 10, 2009) - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (the "Company") today announced that Anglo German Progressive I Limited ("AGP"), represented by Mr. Dirk Hagge, has commenced a legal action against the Company, Dr. Anatoly Langer (the Company's Chairman and interim CEO) and Etienne Grima (the Company's Secretary and Chief Financial Officer) in the Supreme Court of British Columbia. AGP is a shareholder of the Company and is dissatisfied with the affairs of the Company alleging that these have been conducted in a manner specifically oppressive to AGP or are unfairly prejudicial to AGP. The Company notes that during the period of January 2008 to February 2009 Mr. Hagge served as a voting member of the Company's Board of Directors and as a member of the audit and finance committee. As relief, AGP seeks an order directing repayment to AGP all or part of the funds paid by AGP for shares of the Company, with interest, in exchange for all or part of AGP's shares of the Company and removal of Dr. Langer and Mr. Grima as directors of the Company.

The Company believes that AGP's claims are without merit and intends to vigorously defend the action and to seek costs against AGP in addition to such other remedies which may be available to it.

About CardioComm Solutions, Inc.

CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (EKGs), for diagnosis and management of cardiac patients. The Company's products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time EKG viewer. CardioComm is the first company to provide a real-time means of viewing EKGs over a network (LAN, WAN or Internet). This tool enables EKGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global EKG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions, Inc.

Dr. Anatoly Langer, Chairman

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information